These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37853619)

  • 21. Reversal of Dabigatran with Idarucizumab.
    Sodha NR; Sellke FW
    Expert Rev Cardiovasc Ther; 2016 Aug; 14(8):889-93. PubMed ID: 27362456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
    Zarbock A; Küllmar M; Kindgen-Milles D; Wempe C; Gerss J; Brandenburger T; Dimski T; Tyczynski B; Jahn M; Mülling N; Mehrländer M; Rosenberger P; Marx G; Simon TP; Jaschinski U; Deetjen P; Putensen C; Schewe JC; Kluge S; Jarczak D; Slowinski T; Bodenstein M; Meybohm P; Wirtz S; Moerer O; Kortgen A; Simon P; Bagshaw SM; Kellum JA; Meersch M;
    JAMA; 2020 Oct; 324(16):1629-1639. PubMed ID: 33095849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracorporeal hemoadsorption therapy as a potential therapeutic option for rapid removal of Apixaban in high risk-surgical patients: a case report.
    Dalmastri V; Angelini A; Minerva V; Ballarini M; Grammatico F; Todeschini P; Pizzini AM; Silingardi M; La Manna G
    J Med Case Rep; 2023 Jul; 17(1):283. PubMed ID: 37415195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional citrate anticoagulation for renal replacement therapies in patients with acute kidney injury: a position statement of the Work Group "Renal Replacement Therapies in Critically Ill Patients" of the Italian Society of Nephrology.
    Fiaccadori E; Pistolesi V; Mariano F; Mancini E; Canepari G; Inguaggiato P; Pozzato M; Morabito S
    J Nephrol; 2015 Apr; 28(2):151-64. PubMed ID: 25585821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and Safety of Regional Anticoagulation with 4% Trisodium Citrate Versus Heparin in Extended Hemodialysis among Critical Patients with Cancer and Acute Kidney Injury.
    Moura EIM; de Brito GA; Alves JA; Imanishe MH; Baptista AL; Andrade LAS; Pereira BJ
    Blood Purif; 2021; 50(1):50-56. PubMed ID: 32388506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Sustained Low-Efficiency Dialysis.
    Rider TR; Silinskie KM; Hite MS; Bress J
    Pharmacotherapy; 2020 Oct; 40(10):1036-1041. PubMed ID: 32866291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Life-threatening bleeding during dabigatran treatment because of acute renal failure].
    Madsen HB; Lütken SC; Povlsen JA; Løfgren B
    Ugeskr Laeger; 2014; 176(34):. PubMed ID: 25293571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of a citrate-based protocol for sustained low-efficiency dialysis in AKI using standard dialysis equipment.
    Fiaccadori E; Regolisti G; Cademartiri C; Cabassi A; Picetti E; Barbagallo M; Gherli T; Castellano G; Morabito S; Maggiore U
    Clin J Am Soc Nephrol; 2013 Oct; 8(10):1670-8. PubMed ID: 23990164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The safety and efficacy of regional citrate anticoagulation in sustained low efficiency dialysis].
    Zhang L; Wang TL; Zhao YL; Chen ZW; Tang Y; Yang YY; Liao YJ; Fu P
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):459-63. PubMed ID: 24059990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional citrate anticoagulation for RRTs in critically ill patients with AKI.
    Morabito S; Pistolesi V; Tritapepe L; Fiaccadori E
    Clin J Am Soc Nephrol; 2014 Dec; 9(12):2173-88. PubMed ID: 24993448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study.
    Kitchlu A; Adhikari N; Burns KE; Friedrich JO; Garg AX; Klein D; Richardson RM; Wald R
    BMC Nephrol; 2015 Aug; 16():127. PubMed ID: 26238520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simplified regional citrate anticoagulation protocol for CVVH, CVVHDF and SLED focused on the prevention of KRT-related hypophosphatemia while optimizing acid-base balance.
    Di Mario F; Sabatino A; Regolisti G; Pacchiarini MC; Greco P; Maccari C; Vizzini G; Italiano C; Pistolesi V; Morabito S; Fiaccadori E
    Nephrol Dial Transplant; 2023 Sep; 38(10):2298-2309. PubMed ID: 37037771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases.
    Vosko MR; Bocksrucker C; Drwiła R; Dulíček P; Hauer T; Mutzenbach J; Schlimp CJ; Špinler D; Wolf T; Zugwitz D
    J Thromb Thrombolysis; 2017 Apr; 43(3):306-317. PubMed ID: 28210988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained low-efficiency extended dialysis (SLED) with single-pass batch system in critically-ill patients with acute kidney injury (AKI).
    Caires RA; Abdulkader RCRM; Costa E Silva VT; Ferreira GS; Burdmann EA; Yu L; Macedo E
    J Nephrol; 2016 Jun; 29(3):401-409. PubMed ID: 26298845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.
    Kimachi M; Furukawa TA; Kimachi K; Goto Y; Fukuma S; Fukuhara S
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011373. PubMed ID: 29105079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probable drug-drug interaction between dabigatran and quinidine resulting in thrombin time rebound despite multiple idarucizumab doses.
    George S; Taburyanskaya M; Lewis V
    Blood Coagul Fibrinolysis; 2019 Jan; 30(1):42-46. PubMed ID: 30431448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Risk of Acute Kidney Injury with Oral Anticoagulants in Elderly Adults with Atrial Fibrillation.
    Harel Z; McArthur E; Jeyakumar N; Sood MM; Garg AX; Silver SA; Dorian P; Blum D; Beaubien-Souligny W; Yan AT; Badve SV; Smyth B; Jun M; Jandoc R; Kitchlu A; Wald R
    Clin J Am Soc Nephrol; 2021 Oct; 16(10):1470-1479. PubMed ID: 34407990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The hemodynamic tolerability and feasibility of sustained low efficiency dialysis in the management of critically ill patients with acute kidney injury.
    Fieghen HE; Friedrich JO; Burns KE; Nisenbaum R; Adhikari NK; Hladunewich MA; Lapinsky SE; Richardson RM; Wald R;
    BMC Nephrol; 2010 Nov; 11():32. PubMed ID: 21106112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
    Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A
    Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.